Eli Lilly Wins FDA Approval for Inluriyo-Verzenio Combination
Indianapolis, Indiana, September 18, 2026 Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA)...
HER2-negative
Advertisement
LeonaBio Advances Lasofoxifene in Metastatic Breast Cancer
BOTHELL, Wash., August 12, 2026 LeonaBio, Inc. announced that its lead investigational therapy lasofoxifene will be featured in multiple...
Biocon Secures Health Canada Approval for Yesintek Pen
BENGALURU, Karnataka, India, July 29, 2026 Biocon Limited has announced that its Canadian subsidiary has received Health Canada Notice...
IceCure Seeks NCCN Support for Breast Cancer Cryoablation
CAESAREA, Israel, July 29, 2026 IceCure Medical Ltd. has announced a significant development that could broaden the role of...
Phase III Study Shows Giredestrant Boosts Breast Cancer Survival
Basel, Switzerland — September 22, 2025 — Positive phase III trial results from the evERA study reveal that the...
Advertisement
